微RNA作为有前途的治疗剂:从针的角度来看
Sihui Li1, Qianhui Huang1, Qingqing Yang1
1Acupuncture and Moxibustion College, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610075, China.
Pathology, research and practice
|July 5, 2023
概括
微RNAs (miRNAs) 显示出治疗前景,但面临发展障碍. 针调节网络为利用miRNA复杂性提供了一种新的方法,以获得更有效的miRNA治疗方法.
科学领域:
- 综合医学和分子生物学
- 探讨了中国传统医学和现代分子疗法的交叉点.
背景情况:
- 微RNAs (miRNAs) 已因其在疾病中的治疗潜力而得到认可,但面临着重大的发育挑战.
- 目前的miRNA疗法开发受到诸如目标验证,输送,剂量和功能复杂性等问题的阻碍.
- 现有的miRNA候选药物在临床试验中停滞不前,这表明需要创新的开发策略.
研究的目的:
- 探索针调节网络如何克服miRNA治疗开发当前的局限性.
- 为miRNAs,它们的标和针网络之间的相互作用提供跨学科的视角.
- 通过整合针原则来阐明开发新型miRNA治疗方法的挑战和机会.
主要方法:
- 对miRNA疗法和针机制的现有文献的审查.
- 分析针监管网络的三个核心组成部分:针点,神经内分泌免疫 (NEI) 和疾病网络.
- 检查miRNAs作为这些相互连接的针网络中的媒介.
主要成果:
- 识别了针调节网络,作为保护miRNA功能复杂性的潜在解决方案.
- 突出了miRNAs作为针点,NEI和疾病网络中的关键调解者.
- 建议针衍生的miRNAs可能会加速药物开发并降低成本.
结论:
- 利用针衍生的miRNAs是一个有前途的战略,以应对当前miRNA疗法开发的挑战.
- 微RNA研究与针的整合为克服发展障碍提供了新的见解.
- 对针-miRNA相互作用的进一步研究可能会打开新的治疗途径并改善临床结果.
相关概念视频
01:22MicroRNAs
21.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.4K
01:29Microorganisms in Medicine and Therapeutics
64
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
64